In conclusion, in vivo gene silencing of NDUFS8 via AAV delivery significantly inhibited xenograft tumor growth and induced apoptosis, supporting NDUFS8 as a critical promoter of HCC progression. Here, NDUFS8 is linked to hepatocellular carcinoma.